Rare diseases
Investigational molecules
Locations
Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
The sponsor’s research activity includes dMMR tumors across multiple solid tumor types, with interest in colorectal cancer, oesophageal cancer, gastroesophageal junction cancer, gastric cancer, duodenal and small bowel cancer, endometrial cancer, breast cancer, prostate cancer, and sarcoma.
Interest in these cancers reflects a broad focus on tumor biomarker-defined oncology and immunotherapy-responsive disease.
Netherlands Cancer Institute runs clinical trials in conditions such as Mismatch repair cancer syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
